BC Week In Review | Nov 10, 2017
Financial News

EIB backs development of AntibioTx anti-infective

AntibioTx A/S (Hellerup, Denmark) is to receive €20 million ($23.2 million) from a tranched financing with the European Investment Bank to support Phase II and Phase III development of lead candidate ATx201 to treat skin...
BC Extra | Nov 3, 2017
Financial News

EIB backs development of AntibioTx anti-infective

AntibioTx A/S (Hellerup, Denmark) will receive €20 million ($23.2 million) from a tranched financing with the European Investment Bank to support Phase II and Phase III development of lead candidate ATx201 to treat skin infections....
Items per page:
1 - 2 of 2